How has AngioDynamics's interest income (expense), nonoperating changed year-over-year?

AngioDynamics's interest income (expense), nonoperating decreased by 165.2% year-over-year, from $135K to -$88K.

What is the long-term trend for AngioDynamics's interest income (expense), nonoperating?

Over 2 years (2023 to 2025), AngioDynamics's interest income (expense), nonoperating has grown at a -39.8% compound annual growth rate (CAGR), from -$2.7M to $978K.

AngioDynamics ANGO Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

NovantaNOVT

——

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's interest income (expense), nonoperating?: AngioDynamics (ANGO) reported interest income (expense), nonoperating of -$88K in Q4 2025.
How has AngioDynamics's interest income (expense), nonoperating changed year-over-year?: AngioDynamics's interest income (expense), nonoperating decreased by 165.2% year-over-year, from $135K to -$88K.
What is the long-term trend for AngioDynamics's interest income (expense), nonoperating?: Over 2 years (2023 to 2025), AngioDynamics's interest income (expense), nonoperating has grown at a -39.8% compound annual growth rate (CAGR), from -$2.7M to $978K.